In line with the work of Chakraborty et al., the frequency of alterations for SFRP1 was significantly higher in lymph node positive cases (p = 0.025), which is in accordance with the reduced expression seen in the tumor group [16]. The gene discussed is SFRP1; the disease is neoplasm.